Erschienen in:
01.12.2015 | Original Article
The relationship between perioperative administration of inhaled corticosteroid and postoperative respiratory complications after pulmonary resection for non-small-cell lung cancer in patients with chronic obstructive pulmonary disease
verfasst von:
Keiji Yamanashi, Satoshi Marumo, Tsuyoshi Shoji, Takamasa Fukui, Ryota Sumitomo, Yosuke Otake, Minoru Sakuramoto, Motonari Fukui, Cheng-Long Huang
Erschienen in:
General Thoracic and Cardiovascular Surgery
|
Ausgabe 12/2015
Einloggen, um Zugang zu erhalten
Abstract
Objectives
Inhaled corticosteroid (ICS) treatment has been shown to increase the risk of respiratory complications in patients with stable chronic obstructive pulmonary disease (COPD). However, the effects of perioperative ICS treatment on postoperative respiratory complications after lung cancer surgery have not been elucidated. The aim of this study was to investigate whether perioperative ICS treatment would increase the risk of postoperative respiratory complications after lung cancer surgery in patients with COPD.
Methods
We retrospectively analyzed 174 consecutive COPD patients with non-small-cell lung cancer (NSCLC) who underwent lobectomy or segmentectomy between January 2007 and December 2014. Subjects were grouped based on whether or not they were administered perioperative ICS treatment. Postoperative cardiopulmonary complications were compared between the groups.
Results
There were no statistically significant differences in the incidence of postoperative respiratory complications (P = 0.573) between the perioperative ICS treatment group (n = 16) and the control group (n = 158). Perioperative ICS treatment was not significantly associated with postoperative respiratory complications in the univariate or multivariate analysis (odds ratio [OR] = 0.553, 95 % confidence interval [CI] = 0.069–4.452, P = 0.578; OR = 0.635, 95 % CI = 0.065–6.158, P = 0.695, respectively). Kaplan–Meier analysis showed that there were no statistically significant differences in the postoperative respiratory complications-free durations between the groups (P = 0.566), even after propensity score matching (P = 0.551).
Conclusion
There was no relationship between perioperative ICS administration and the incidences of postoperative respiratory complications after surgical resection for NSCLC in COPD patients.